missing translation for 'onlineSavingsMsg'
Learn More
Learn More
CRMP1 Polyclonal Antibody, Invitrogen™
Rabbit Polyclonal Antibody
Marca: Invitrogen PA520677
Questo articolo non è restituibile.
Consulta la politica di reso
Descrizione
A suggested positive control is rat brain tissue lysate. PA5-20677 can be used with blocking peptide PEP-0795.
Collapsin-response mediator proteins (CRMPs) are highly expressed in the developing brain where they play major roles in axonal outgrowth, neurite differentiation, and apoptosis. Their continued expression in areas of high synaptic remodeling such as the cerebellum, hippocampus, and the olfactory system suggests that these proteins may also be involved in adult brain plasticity. CRMP-1 was initially identified as a dihydro-pyrimidinase expressed exclusively in brain; later studies have shown that it is involved with neurotrophin (NT) 3-induced neurite formation and outgrowth. CRMP-1 localization switches from axonal to somatodendritic when neurons reach functional maturity, suggesting that it is involved in early neuronal differentiation as well as in later processes related to the survival or death of the newly generated neurons.
Specifica
CRMP1 | |
Polyclonal | |
Unconjugated | |
CRMP1 | |
Collapsin response mediator protein 1; Crmp1; CRMP-1; dihydropyrimidinase-like 1; dihydropyrimidinase-related protein 1; Dpysl1; DRP1; DRP-1; Ulip3; ULIP-3; Unc-33-like phosphoprotein 3 | |
Rabbit | |
Antigen affinity chromatography | |
RUO | |
12933, 1400, 25415 | |
Maintain refrigerated at 2-8°C for up to 3 months. For long term storage store at -20°C | |
Liquid |
Immunohistochemistry, Western Blot | |
1 mg/mL | |
PBS with 0.02% sodium azide | |
P97427, Q14194, Q62950 | |
CRMP1 | |
An 18 amino acid peptide from near the amino terminus of human CRMP1. | |
100 μg | |
Primary | |
Human, Mouse, Rat | |
Antibody | |
IgG |
Correzione del contenuto del prodotto
Fornite il vostro feedback sul contenuto del prodotto compilando il modulo sottostante.
Titolo del prodotto
Individuate un'opportunità di miglioramento?Condividi una correzione di contenuto